ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Pediatric Schizophrenia Efficacy and Safety Study

ClinicalTrials.gov ID: NCT01911429

Public ClinicalTrials.gov record NCT01911429. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 7:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia

Study identification

NCT ID
NCT01911429
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
327 participants

Conditions and interventions

Conditions

Interventions

  • Lurasidone 40 mg Drug
  • Lurasidone 80 mg Drug
  • Placebo 40 or 80 mg Drug

Drug

Eligibility (public fields only)

Age range
13 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2013
Primary completion
Nov 30, 2015
Completion
Nov 30, 2015
Last update posted
Apr 17, 2017

2013 – 2015

United States locations

U.S. sites
36
U.S. states
18
U.S. cities
36
Facility City State ZIP Site status
Harmonex Neuroscience Research Dothan Alabama 36303
California Pharmaceutical Research Institute, Inc Anaheim California 92804
Central Valley Medical Research Bakersfield California 93311
ProScience Research Group Culver City California 90230
Diligent Clinical Trials, Inc Downey California 90241
Collaborative Neuroscience Network, LLC Garden Grove California 92845
Global Clinical Trials, LLC Irvine California 92614
Neuropsychiatric Research Center of Orange County Orange California 92868
Asclepes Research Panorama City California 91402
CITrials, Inc. - Riverside & San Bernardino County Riverside California 92506
Hartford Hospital Hartford Connecticut 06106
Children's National Medical Center Washington D.C. District of Columbia 20010
Florida Clinical Research Center, LLC Bradenton Florida 34201
Sarkis Clinical Trials - Parent Gainesville Florida 32607
APG Research, LLC Orlando Florida 32803
Medical Research Group of Central Florida Sanford Florida 32771
Atlanta Center for Medical Research Atlanta Georgia 30308
Institute for Behavioral Medicine, LLC Smyrna Georgia 30080
Baber Research Group Naperville Illinois 60563
Lake Charles Clinical Trials, LLC Lake Charles Louisiana 70629
Kennedy Krieger Institute Baltimore Maryland 21205
Neurobehavioral Medicine Group, PLLC Bloomfield Hills Michigan 48302
Jersey Shore University Medical Center Neptune City New Jersey 07753
Manhattan Behavioral Medicine, LLC New York New York 10022
Finger Lakes Clinical Research Rochester New York 14618
Richmond Behavioral Associates Staten Island New York 10312
University of Cincinnati Medical Center Cincinnati Ohio 45219
University Hospitals Case Medical Center Cleveland Ohio 44106
Cutting Edge Research Group Oklahoma City Oklahoma 73116
Research Strategies of Memphis, LLC Memphis Tennessee 38119
BioBehavioral Research of Austin Austin Texas 78759
Pillar Clinical Research, LLC Dallas Texas 75243
BioBehavioral Research of Austin El Campo Texas 77437
Family Psychiatry of The Woodlands, P.A. The Woodlands Texas 77381
Aspen Clinical Research Orem Utah 84058
University of Virginia Charlottesville Virginia 22903

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01911429, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2017 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01911429 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →